COVID-19疫情期间癌症手术中断导致大量手术推迟和取消，导致手术积压，给医疗机构在疫情恢复阶段带来了挑战。该队列研究旨在描述COVID-19疫情期间重度泌尿系癌症手术的手术量和术后住院时间变化的模式。该研究从2016年第一季度（Q1）到2021年第二季度（Q2）在宾夕法尼亚州医疗保健成本控制委员会数据库中识别了24001名年龄在18岁或以上的肾癌、前列腺癌或膀胱癌患者，接受了根治性肾切除术、部分肾切除术、根治性前列腺切除术或根治性膀胱切除术。比较了COVID-19疫情期间与疫情之前的术后住院时间和手术量。主要结果是COVID-19疫情期间重度泌尿系癌症根治性和部分肾切除术、根治性前列腺切除术和根治性膀胱切除术的手术量。次要结果是术后住院时间。该研究表明，COVID-19疫情期间，部分肾切除术和根治性前列腺切除术的手术量减少了，部分肾切除术的术后住院时间也减少了。

Disruptions in cancer surgery during the COVID-19 pandemic led to widespread deferrals and cancellations, creating a surgical backlog that presents a challenge for health care institutions moving into the recovery phase of the pandemic.To describe patterns in surgical volume and postoperative length of stay for major urologic cancer surgery during the COVID-19 pandemic.This cohort study identified 24 001 patients 18 years or older from the Pennsylvania Health Care Cost Containment Council database with kidney cancer, prostate cancer, or bladder cancer who received a radical nephrectomy, partial nephrectomy, radical prostatectomy, or radical cystectomy between the first quarter (Q1) of 2016 and Q2 of 2021. Postoperative length of stay and adjusted surgical volumes were compared before and during the COVID-19 pandemic.The primary outcome was adjusted surgical volume for radical and partial nephrectomy, radical prostatectomy, and radical cystectomy during the COVID-19 pandemic. The secondary outcome was postoperative length of stay.A total of 24 001 patients (mean [SD] age, 63.1 [9.4] years; 3522 women [15%], 19 845 White patients [83%], 17 896 living in urban areas [75%]) received major urologic cancer surgery between Q1 of 2016 and Q2 of 2021. Of these, 4896 radical nephrectomy, 3508 partial nephrectomy, 13 327 radical prostatectomy, and 2270 radical cystectomy surgical procedures were performed. There were no statistically significant differences in patient age, sex, race, ethnicity, insurance status, urban or rural status, or Elixhauser Comorbidity Index scores between patients who received surgery before and patients who received surgery during the pandemic. For partial nephrectomy, a baseline of 168 surgeries per quarter decreased to 137 surgeries per quarter in Q2 and Q3 of 2020. For radical prostatectomy, a baseline of 644 surgeries per quarter decreased to 527 surgeries per quarter in Q2 and Q3 of 2020. However, the likelihood of receiving radical nephrectomy (odds ratio [OR], 1.00; 95% CI, 0.78-1.28), partial nephrectomy (OR, 0.99; 95% CI, 0.77-1.27), radical prostatectomy (OR, 0.85; 95% CI, 0.22-3.22), or radical cystectomy (OR, 0.69; 95% CI, 0.31-1.53) was unchanged. Length of stay for partial nephrectomy decreased from baseline by a mean of 0.7 days (95% CI, -1.2 to -0.2 days) during the pandemic.This cohort study suggests that partial nephrectomy and radical prostatectomy surgical volume decreased during the peak waves of COVID-19, as did postoperative length of stay for partial nephrectomy.